Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Mignot (Kontich, Belgium), D. Belmans (Kontich, Belgium), G. Poli (Parma, Italy), V. Mongelli (Parma, Italy), D. Cocconi (Parma, Italy), D. Guastalla (Parma, Italy). Late Breaking Abstract - Lung deposition of two different ICS/LABA combinations with Dry Powder Inhaler (DPI) in asthmatic patients using Functional Respiratory Imaging (FRI).. 4822

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Factors associated with health-status of COPD patients on Dry Powder Inhaler (DPI) maintenance therapy Source: Virtual Congress 2021 – Highlights for primary care in 2021 Year: 2021 Late Breaking Abstract - Dry Powder Inhaler Preference in asthma patients. Results of the DPI PREFER Study Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020 Lung deposition of extrafine vs non-extrafine triple therapies in patients with COPD using Functional Respiratory Imaging (FRI). Source: International Congress 2019 – Imaging in respiratory disease: novel technologies in 2019 Year: 2019 Cost Effectiveness Comparison of a Dry Powder Inhaler to a Metered Dose Inhaler plus Valved Holding Chamber based on a Functional Respiratory Imaging (FRI) Model Source: Virtual Congress 2021 – Difficult decisions on expected outcomes: availability of hospital resources and improvement of treatment adherence Year: 2021 Lung deposition of extrafine inhaled corticosteroid (ICS)-containing fixed combinations drug in COPD patients using Functional Respiratory Imaging (FRI). Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018 Late Breaking Abstract - Functional respiratory imaging (FRI) and lung function assessment of glycopyrronium/formoterol fumarate dihydrate fixed-dose combination delivered using novel Co-Suspension Delivery Technology (GFF MDI) in COPD Source: International Congress 2017 – Novel studies on bronchodilators and cough Year: 2017 Evaluation of inhalant deposition of ICS/LABA in the peripheral airway of asthma patients using Functional Respiratory Imaging (FRI) Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Late Breaking Abstract - Effectiveness of Fluticasone furoate/vilanterol (FF/VI) compared to usual care (UC) in patients with asthma: The Salford Lung Study (SLS) Source: International Congress 2017 – Late-breaking studies in asthma and COPD Year: 2017 Late Breaking Abstract - Effects of a new Airway Clearance Technology versus manual physiotherapy in COPD Source: International Congress 2018 – Functional assessment of COPD Year: 2018 Late Breaking Abstract - Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF) Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Interstitial lung diseases and pulmonary hypertension Year: 2019 Comparison of the particle size distribution of fluticasone propionate/formoterol and beclometasone/formoterol MDI using laser diffraction Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Late Breaking Abstract - Assessment of disease progression in IPF patients using Functional Respiratory Imaging (FRI) Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems Year: 2017 Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study. Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Safety and Feasibility of Metered CryoSpray (MCS) for Patients with Chronic Bronchitis in COPD: 9 Month Results. Source: International Congress 2019 – Bronchoscopic treatment of COPD: hot news Year: 2019 Inspiratory flow resistance of marketed dry powder inhalers (DPI) Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases Year: 2014 LATE-BREAKING ABSTRACT: Blood Eosinophil Count as a Biomarker of ICS Effectiveness in Reducing Exacerbation Rates in COPD Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Cost Effectiveness Comparison of a Dry Powder Inhaler to a Metered Dose Inhaler plus Valved Holding Chamber based on an In-Vitro Drug Delivery Model Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 Z7200 versus Symbicort® Turbohaler®: A pharmacodynamic evaluation of the acute effects using functional respiratory imaging (FRI) Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Late Breaking Abstract - Inhaled corticosteroids (ICS), blood eosinophils (EOS), and FEV1 decline in patients with Chronic Obstructive Pulmonary Disease in a large UK primary healthcare setting Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018 Late Breaking Abstract - Extrafine single inhaler triple therapy improves quality of life in COPD. Analysis of SGRQ subdomains of the TRIBUTE Study Source: International Congress 2018 – COPD: from LABA/ICS to LABA/LAMA/ICS Year: 2018